Initial Data from Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia to be Presented, Along with Initial Findings ...
In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Crinetics Pharmaceuticals (CRNX – Research ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the launch of WHAT THE C@H?!, an educational initiative that aims to close the gap in the need for helpful information about congenital ...
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. The ...
Adrenocorticotropic hormone (ACTH) is a hormone that regulates cortisol. In rare cases, an ACTH-secreting tumor causes Cushing’s syndrome. This kind of tumor can form in an organ that doesn’t ...
When a non-cancerous (benign) tumor sits on the pituitary, the gland makes too much of a hormone called ACTH. In response, the adrenal glands above each kidney produce too much cortisol ...
THE surgical management of craniopharyngiomas, whether radical or conservative, has always been hazardous. Gordy, Peet and Kahn 1 reported a series of 51 cases in which the operative mortality was ...
In some instances, rapid withdrawal from adrenal suppressive medications (steroids), pituitary surgery and cancer can also result in a deficiency of the adrenocorticotropic hormone (ACTH), according ...